Ablation is the standard therapy for many arrhythmias but is not always feasible due to cost, long wait lists, or patient fear. As a result, antiarrhythmic drugs continue to be commonly prescribed by arrhythmologists. The document then lists several common antiarrhythmic drugs, their trade names, pharmacological names, drug classes, manufacturers, doses, and prices. It provides guidance on using specific drugs for various arrhythmias but notes the report does not cover side effects or precautions.

1. Antiarrhythmic drugs. Prepared by Prof. Samir Rafla
Ablation is the standard therapy of many arrhythmias but is not feasible easily because of cost
or long waiting list or fear of patients. So, antiarrhythmic drugs will continue to be the
available handy tool in the prescriptions of the arrhythmologist.
Trade
name
Pharmacologic
name
Class Company Dose Price Eg. Pound
Mexitil Mexiletine 200 mg Ib Boehringer 1x3 138 (100 cap)
Norpace Disopyramide 100
mg
Ia Searle 1x3 4.5 (20 cap)
Rytmonorm Propafenone 150
mg
Ic Adco/Knoll 1x3 28 (20 tab)
Cordarone Amiodarone 200
mg
III Sanofi
aventis
1/ 2 to 1x3 18 (30 tab)
Tambocor Flecainide 100 mg Ic Health Care
limited
1x1 410/ 60 tab
Adencor Adenosin 6 mg
amp
S.
Synthelabo
1 can add
2
545/ 6 vial
Xylocard Lidocain 2%. 20% Ib AstraZenica 50 mg IV 18 or 40
Isoptin Verapamil amp 5
mg
IV Adco/Knoll 5 mg /2ml
amp
75 /amp
Multak Dronedarone 200
mg
III Sanofi
aventis
1x2 700 / 30 tab
Procoralan Ivabradin 5, 7.5 mg Servier 1x2 196 / 28 tab
Betacor Sotalol 80 mg III Amoun 1 or 1x3 12 / 30 tab
For supraventricular arrhythmias: propafenone, sotalol, verapamil can be used; also
amiodarone. For maintenance of sinus rhythm in atrial fibrillation: use propafenone,
Flecainide, Dronedarone or amiodarone. For ventricular arrhythmias use Disopyramide,
Mexiletine, amiodarone or sotalol. For inappropriate sinus node tachycardia use Ivabradin or
beta blockers. This report is very short, side effects and precautions are not mentioned. Don't
prescribe drug without knowing the precautions. For correspondence smrafla@yahoo.com